Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03225807 · ClinicalTrials.gov registry record
Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 8,692
- Enrollment target
NCT03225807: Completed study, sponsored by Intermountain Health Care.
NCT03225807 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 8,692 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03225807 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 8,692 participants
- Enrollment target
Study Summary
This is a quality improvement study with the purpose of observing and measuring the effects of implementation of a proven standardized lung protective ventilation protocol in the new electronic medical record system iCentra across all Intermountain Healthcare hospitals. Approximately 14,000 records will be accessed for this study from a database of mechanically ventilated patients established for quality improvement purposes. The investigators hypothesize that implementation of a standardized computerized lung protective ventilation protocol across all Intermountain Healthcare hospitals will be feasible, will decrease initial tidal volumes to the target 6 ml/kg PBW, and will improve outcomes. The objectives of this study are to: * Determine if the implementation of lung protective ventilation (with a 6 ml/kg PBW tidal volume ventilation protocol on initiation of mechanical ventilation) improves outcomes in patients with acute respiratory failure requiring mechanical ventilation * Determine if the implementation of lung protective ventilation (with a 6 ml/kg PBW tidal volume ventilation protocol on initiation of mechanical ventilation) improves outcomes in the sub-group of patients with the acute respiratory distress syndrome (ARDS) * Measure compliance with the implementation of a computerized lung protective ventilation protocol at 12 Intermountain Healthcare hospitals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,692 participants |
| Start Date | 2016-03 |
| Est. Completion | 2022-12-01 |
What the finished NCT03225807 record still lists
NCT03225807 is an observational study that tracks outcomes without assigning an intervention. Its 8,692 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03225807 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03225807 about?
NCT03225807 is a clinical study titled "Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure". This is a quality improvement study with the purpose of observing and measuring the effects of implementation of a proven standardized lung protective ventilation protocol in the new electronic medical record system iCentra across all Intermountain Healthcare hospitals. Approximately 14,000 records ...
What is the current status of trial NCT03225807?
This trial is currently completed. The enrollment target is 8,692 participants. The study started on 2016-03. Estimated completion is 2022-12-01.
Who is sponsoring clinical trial NCT03225807?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia